H
HLB Life Science Co Ltd
KOSDAQ:067630
HLB Life Science Co Ltd
KOSDAQ:067630
Price:
4 850
KRW
12.79%
Market Closed
Market Cap:
₩591.3B
Balance Sheet
Balance Sheet Decomposition
HLB Life Science Co Ltd
HLB Life Science Co Ltd
Balance Sheet Decomposition is not available for
HLB Life Science Co Ltd
HLB Life Science Co Ltd
Balance Sheet
HLB Life Science Co Ltd
HLB Life Science Co Ltd
Currency: KRW
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
2 120
|
747
|
2 310
|
2 389
|
15 589
|
4 156
|
13 445
|
16 862
|
36 769
|
37 157
|
31 254
|
30 978
|
|
| Cash |
3
|
747
|
1
|
0
|
0
|
2
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2 117
|
0
|
2 309
|
2 389
|
15 589
|
4 154
|
13 440
|
16 862
|
36 769
|
37 157
|
31 254
|
30 978
|
|
| Short-Term Investments |
2 511
|
3 454
|
2 849
|
2 549
|
7 466
|
9 227
|
16 816
|
177 929
|
138 987
|
120 877
|
108 707
|
97 293
|
|
| Total Receivables |
23 574
|
13 644
|
11 993
|
7 883
|
4 817
|
34 153
|
38 759
|
34 241
|
40 735
|
19 821
|
14 464
|
17 301
|
|
| Accounts Receivables |
22 655
|
13 185
|
10 613
|
6 406
|
3 733
|
31 758
|
31 964
|
32 388
|
38 488
|
17 759
|
11 786
|
12 942
|
|
| Other Receivables |
919
|
459
|
1 380
|
1 477
|
1 084
|
2 395
|
6 795
|
1 853
|
2 247
|
2 062
|
2 678
|
4 358
|
|
| Inventory |
3
|
946
|
0
|
2 646
|
3 453
|
7 178
|
4 911
|
5 854
|
7 149
|
2 082
|
1 769
|
10 867
|
|
| Other Current Assets |
618
|
485
|
18 546
|
1 654
|
693
|
247
|
520
|
4 199
|
27
|
1 392
|
629
|
4 337
|
|
| Total Current Assets |
28 827
|
19 277
|
35 698
|
17 121
|
32 018
|
54 960
|
74 451
|
239 086
|
223 667
|
181 329
|
156 822
|
160 776
|
|
| PP&E Net |
2 388
|
10 108
|
3 079
|
3 538
|
3 378
|
3 586
|
3 284
|
747
|
23 056
|
22 935
|
22 081
|
92 089
|
|
| PP&E Gross |
2 388
|
10 108
|
3 079
|
0
|
0
|
3 586
|
3 284
|
747
|
23 056
|
22 935
|
22 081
|
92 089
|
|
| Accumulated Depreciation |
411
|
570
|
402
|
0
|
0
|
4 670
|
989
|
1 174
|
8 104
|
9 917
|
10 967
|
18 897
|
|
| Intangible Assets |
52
|
39
|
52
|
5 322
|
1 029
|
3 615
|
1 519
|
71 870
|
73 749
|
75 440
|
62 809
|
69 506
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
586
|
586
|
48 801
|
22 603
|
1 896
|
0
|
21 925
|
|
| Note Receivable |
27 655
|
12 297
|
7 057
|
5 506
|
3 697
|
1 628
|
535
|
1 249
|
1 430
|
687
|
480
|
482
|
|
| Long-Term Investments |
2 407
|
2 548
|
2 340
|
1 907
|
2 578
|
18 303
|
18 123
|
23 346
|
60 393
|
44 434
|
28 140
|
65 238
|
|
| Other Long-Term Assets |
1 557
|
1 599
|
0
|
0
|
0
|
0
|
520
|
1 156
|
37
|
476
|
468
|
1 775
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
586
|
586
|
48 801
|
22 603
|
1 896
|
0
|
21 925
|
|
| Total Assets |
62 885
N/A
|
45 868
-27%
|
48 225
+5%
|
33 394
-31%
|
42 699
+28%
|
82 678
+94%
|
99 018
+20%
|
386 255
+290%
|
404 935
+5%
|
327 197
-19%
|
270 800
-17%
|
411 790
+52%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
4 698
|
2 485
|
6 821
|
4 053
|
5 295
|
27 547
|
29 755
|
22 805
|
26 726
|
5 548
|
10 278
|
9 384
|
|
| Accrued Liabilities |
143
|
248
|
46
|
0
|
0
|
793
|
278
|
429
|
566
|
584
|
718
|
697
|
|
| Short-Term Debt |
6 959
|
7 786
|
4 000
|
1 041
|
3 273
|
3 969
|
1 080
|
1 405
|
700
|
0
|
0
|
7 920
|
|
| Current Portion of Long-Term Debt |
11 116
|
7 015
|
8 670
|
5 401
|
172
|
1 560
|
1 600
|
12 217
|
699
|
378
|
668
|
2 532
|
|
| Other Current Liabilities |
4 697
|
6 366
|
10 119
|
4 736
|
5 794
|
2 853
|
3 838
|
11 781
|
11 153
|
11 355
|
1 872
|
6 251
|
|
| Total Current Liabilities |
27 613
|
23 901
|
29 657
|
15 232
|
14 533
|
36 721
|
36 551
|
48 639
|
39 845
|
17 865
|
13 536
|
26 785
|
|
| Long-Term Debt |
19 551
|
12 879
|
6 896
|
4 342
|
2 156
|
17 635
|
8 719
|
80 074
|
10 575
|
11 014
|
3 953
|
137 021
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
225
|
500
|
14 121
|
10 225
|
9 667
|
5 758
|
10 033
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 154
|
602
|
563
|
423
|
1 342
|
|
| Other Liabilities |
488
|
2 046
|
638
|
380
|
115
|
412
|
421
|
22 183
|
9 865
|
907
|
941
|
1 884
|
|
| Total Liabilities |
47 651
N/A
|
38 827
-19%
|
37 191
-4%
|
19 953
-46%
|
16 804
-16%
|
54 993
+227%
|
46 192
-16%
|
167 170
+262%
|
71 112
-57%
|
40 016
-44%
|
24 611
-38%
|
177 065
+619%
|
|
| Equity | |||||||||||||
| Common Stock |
3 243
|
3 243
|
6 743
|
7 153
|
12 310
|
12 310
|
13 812
|
18 623
|
24 002
|
24 009
|
48 223
|
48 831
|
|
| Retained Earnings |
182
|
8 223
|
3 968
|
1 390
|
15 574
|
16 798
|
6 636
|
3 546
|
192
|
59 848
|
46 445
|
40 698
|
|
| Additional Paid In Capital |
12 801
|
12 538
|
8 035
|
4 223
|
29 160
|
32 181
|
31 987
|
200 885
|
284 025
|
284 114
|
230 875
|
209 442
|
|
| Unrealized Security Profit/Loss |
82
|
0
|
230
|
0
|
0
|
9
|
20
|
3 470
|
25 638
|
34 852
|
9 549
|
9 591
|
|
| Treasury Stock |
499
|
499
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
48
|
18
|
5
|
675
|
2
|
1
|
411
|
498
|
350
|
4 055
|
3 988
|
7 558
|
|
| Total Equity |
15 234
N/A
|
7 041
-54%
|
11 034
+57%
|
13 441
+22%
|
25 895
+93%
|
27 685
+7%
|
52 826
+91%
|
219 086
+315%
|
333 823
+52%
|
287 181
-14%
|
246 189
-14%
|
234 725
-5%
|
|
| Total Liabilities & Equity |
62 885
N/A
|
45 868
-27%
|
48 225
+5%
|
33 394
-31%
|
42 699
+28%
|
82 678
+94%
|
99 018
+20%
|
386 255
+290%
|
404 935
+5%
|
327 197
-19%
|
270 800
-17%
|
411 790
+52%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
16
|
23
|
38
|
29
|
51
|
51
|
57
|
73
|
94
|
94
|
103
|
102
|
|
Switch to:
Switch to:
See Also
Discover More
